173 related articles for article (PubMed ID: 37254023)
21. A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology.
Kloos RT; Monroe RJ; Traweek ST; Lanman RB; Kennedy GC
Thyroid; 2016 Jun; 26(6):785-93. PubMed ID: 26992356
[TBL] [Abstract][Full Text] [Related]
22. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
23. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.
Papi G; Corsello SM; Cioni K; Pizzini AM; Corrado S; Carapezzi C; Fadda G; Baldini A; Carani C; Pontecorvi A; Roti E
J Endocrinol Invest; 2006 May; 29(5):427-37. PubMed ID: 16794366
[TBL] [Abstract][Full Text] [Related]
24. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.
Trimboli P; Guidobaldi L; Bongiovanni M; Crescenzi A; Alevizaki M; Giovanella L
Diagn Cytopathol; 2016 Jan; 44(1):45-51. PubMed ID: 26481456
[TBL] [Abstract][Full Text] [Related]
25. Head-to-head comparison of FNA cytology vs. calcitonin measurement in FNA washout fluids (FNA-CT) to diagnose medullary thyroid carcinoma. A systematic review and meta-analysis.
Trimboli P; Giannelli J; Marques B; Piccardo A; Crescenzi A; Deandrea M
Endocrine; 2022 Jan; 75(1):33-39. PubMed ID: 34606057
[TBL] [Abstract][Full Text] [Related]
26. Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents.
Eckelt F; Pfaeffle R; Kiess W; Kratzsch J
J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1491-1504. PubMed ID: 34543539
[TBL] [Abstract][Full Text] [Related]
27. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
[TBL] [Abstract][Full Text] [Related]
28. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
[TBL] [Abstract][Full Text] [Related]
29. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis.
Cheung K; Roman SA; Wang TS; Walker HD; Sosa JA
J Clin Endocrinol Metab; 2008 Jun; 93(6):2173-80. PubMed ID: 18364376
[TBL] [Abstract][Full Text] [Related]
30. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis.
Trimboli P; Treglia G; Guidobaldi L; Romanelli F; Nigri G; Valabrega S; Sadeghi R; Crescenzi A; Faquin WC; Bongiovanni M; Giovanella L
Clin Endocrinol (Oxf); 2015 Feb; 82(2):280-5. PubMed ID: 25047365
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
32. Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease.
Rink T; Truong PN; Schroth HJ; Diener J; Zimny M; Grünwald F
Thyroid; 2009 Apr; 19(4):327-32. PubMed ID: 19355822
[TBL] [Abstract][Full Text] [Related]
33. Determinants of circulating calcitonin value: analysis of thyroid features, demographic data, anthropometric characteristics, comorbidities, medications, and smoking habits in a population with histological full exclusion of medullary thyroid carcinoma.
Trimboli P; Peloni G; Confalonieri D; Gamarra E; Piticchio T; Frasca F; Makovac P; Piccardo A; Ruinelli L
Front Oncol; 2024; 14():1278816. PubMed ID: 38347847
[TBL] [Abstract][Full Text] [Related]
34. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens.
Kudo T; Miyauchi A; Ito Y; Takamura Y; Amino N; Hirokawa M
Thyroid; 2007 Jul; 17(7):635-8. PubMed ID: 17696833
[TBL] [Abstract][Full Text] [Related]
36. The dilemma of routine testing for calcitonin thyroid nodule's patients to detect or exclude medullary carcinoma: one single negative test should be valuable as rule-out strategy to avoid further calcitonin measurements over time.
Trimboli P; Camponovo C; Ruinelli L
Endocrine; 2022 Jun; 77(1):80-85. PubMed ID: 35391593
[TBL] [Abstract][Full Text] [Related]
37. Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada.
Daniels GH
Thyroid; 2011 Nov; 21(11):1199-207. PubMed ID: 21936671
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
[TBL] [Abstract][Full Text] [Related]
39. Does pretreatment elevated calcitonin level cause the poor prognosis in patients with medullary thyroid cancer?
Zhang H; Zhang D; Sui C; Li J; Li C; He Q; Du R; Zhao Y; Fu Y; Zhou L; Wang T; Dionigi G; Liang N; Sun H
Ann Transl Med; 2022 Jun; 10(12):709. PubMed ID: 35845523
[TBL] [Abstract][Full Text] [Related]
40. Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation.
Biamonte E; Solbiati L; Ierace T; Colombo P; Lavezzi E; Mazziotti G; Lania A
Endocrine; 2019 Sep; 65(3):515-519. PubMed ID: 31273680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]